A qualitative exploration of the patient experience of erosive and non-erosive hand osteoarthritis.

Concept elicitation Hand osteoarthritis Michigan Hand Outcomes Questionnaire Patient-experience Patient-reported outcomes Qualitative interviews Real-time data capture

Journal

Journal of patient-reported outcomes
ISSN: 2509-8020
Titre abrégé: J Patient Rep Outcomes
Pays: Germany
ID NLM: 101722688

Informations de publication

Date de publication:
03 Feb 2021
Historique:
received: 07 01 2020
accepted: 07 01 2021
entrez: 4 2 2021
pubmed: 5 2 2021
medline: 5 2 2021
Statut: epublish

Résumé

Many patients with hand osteoarthritis (HOA) experience reduced health-related quality of life. This study sought to better understand the disease and treatment experience of individuals with HOA, explore any differences in experiences between erosive and non-erosive HOA sub-types, and evaluate content validity of the Michigan Hand Outcomes Questionnaire (MHQ) in HOA. Thirty subjects from the United States (n = 15 erosive HOA; n = 15 non-erosive HOA) participated in semi-structured interviews: concept elicitation explored symptoms/impacts important to patients; cognitive interviews assessed understanding and relevance of the MHQ. A sub-sample participated in real-time data capture (RTDC) activities via a smartphone/tablet app over 7 days. Verbatim transcripts were coded using Atlas.ti software and thematically analyzed. Concept saturation and MHQ content validity were evaluated. Most participants reported experiencing pain, swelling and stiffness, symptoms that most commonly had a direct impact on physical functioning. Substantial impacts on activities of daily living, emotional functioning, sleep and work were also reported. RTDC findings corroborated concept elicitation findings. There were no notable differences between erosive and non-erosive HOA, except nodules were reported more frequently in erosive disease. Most participants used analgesic treatments, but effects were short-lived. Pain was the symptom most frequently reported as most bothersome and important to treat. Concept saturation was achieved. MHQ items and instructions were well understood and relevant to most participants; stiffness and swelling were reported as important symptoms not included in the MHQ. This study characterizes key symptoms of HOA which are burdensome for patients and not well controlled by current therapies, highlighting an unmet treatment need. Although the study is limited by a small sample size that may not be representative of the broader erosive and non-erosive HOA population, concept saturation was achieved, and our findings suggest that disease experience is similar for patients with erosive and non-erosive HOA. Evaluation of stiffness and swelling items in conjunction with the MHQ may enhance relevance and improve measurement precision to assess important domains of HQRoL in an HOA population.

Sections du résumé

BACKGROUND BACKGROUND
Many patients with hand osteoarthritis (HOA) experience reduced health-related quality of life. This study sought to better understand the disease and treatment experience of individuals with HOA, explore any differences in experiences between erosive and non-erosive HOA sub-types, and evaluate content validity of the Michigan Hand Outcomes Questionnaire (MHQ) in HOA.
METHODS METHODS
Thirty subjects from the United States (n = 15 erosive HOA; n = 15 non-erosive HOA) participated in semi-structured interviews: concept elicitation explored symptoms/impacts important to patients; cognitive interviews assessed understanding and relevance of the MHQ. A sub-sample participated in real-time data capture (RTDC) activities via a smartphone/tablet app over 7 days. Verbatim transcripts were coded using Atlas.ti software and thematically analyzed. Concept saturation and MHQ content validity were evaluated.
RESULTS RESULTS
Most participants reported experiencing pain, swelling and stiffness, symptoms that most commonly had a direct impact on physical functioning. Substantial impacts on activities of daily living, emotional functioning, sleep and work were also reported. RTDC findings corroborated concept elicitation findings. There were no notable differences between erosive and non-erosive HOA, except nodules were reported more frequently in erosive disease. Most participants used analgesic treatments, but effects were short-lived. Pain was the symptom most frequently reported as most bothersome and important to treat. Concept saturation was achieved. MHQ items and instructions were well understood and relevant to most participants; stiffness and swelling were reported as important symptoms not included in the MHQ.
CONCLUSIONS CONCLUSIONS
This study characterizes key symptoms of HOA which are burdensome for patients and not well controlled by current therapies, highlighting an unmet treatment need. Although the study is limited by a small sample size that may not be representative of the broader erosive and non-erosive HOA population, concept saturation was achieved, and our findings suggest that disease experience is similar for patients with erosive and non-erosive HOA. Evaluation of stiffness and swelling items in conjunction with the MHQ may enhance relevance and improve measurement precision to assess important domains of HQRoL in an HOA population.

Identifiants

pubmed: 33537932
doi: 10.1186/s41687-021-00286-1
pii: 10.1186/s41687-021-00286-1
pmc: PMC7859145
doi:

Types de publication

Journal Article

Langues

eng

Pagination

18

Subventions

Organisme : GlaxoSmithKline
ID : NA

Références

Expert Rev Pharmacoecon Outcomes Res. 2010 Jun;10(3):269-81
pubmed: 20545592
Clin Geriatr Med. 2010 Aug;26(3):387-99
pubmed: 20699161
Ann Rheum Dis. 2010 Oct;69(10):1784-8
pubmed: 20410068
Qual Life Res. 2010 Oct;19(8):1087-96
pubmed: 20512662
Ann Rheum Dis. 2010 Mar;69(3):585-7
pubmed: 20124359
Ann Rheum Dis. 2005 Nov;64(11):1633-8
pubmed: 15829571
J Patient Rep Outcomes. 2017;1(1):9
pubmed: 29757313
Hand (N Y). 2012 Sep;7(3):335-40
pubmed: 23997745
Lancet. 2011 Jun 18;377(9783):2115-26
pubmed: 21684382
Osteoarthritis Cartilage. 2002 Nov;10(11):855-62
pubmed: 12435330
Arthritis Rheum. 2007 Dec 15;57(8):1404-9
pubmed: 18050180
J Rheumatol. 2004 Oct;31(10):1996-2001
pubmed: 15468366
Ann Rheum Dis. 2019 Jan;78(1):16-24
pubmed: 30154087
J Patient Rep Outcomes. 2019 Dec 30;3(1):75
pubmed: 31889232
Psychol Health. 2010 Dec;25(10):1229-45
pubmed: 20204937
JAMA. 1995 Jan 4;273(1):59-65
pubmed: 7996652
Ann Rheum Dis. 2011 Sep;70(9):1581-6
pubmed: 21622766
Osteoarthritis Cartilage. 2002 Nov;10(11):863-9
pubmed: 12435331
Chronic Illn. 2010 Jun;6(2):101-10
pubmed: 20444766
Semin Arthritis Rheum. 2014 Oct;44(2):145-54
pubmed: 24928208
Best Pract Res Clin Rheumatol. 2010 Jun;24(3):301-12
pubmed: 20534365
Ann Rheum Dis. 2015 Oct;74(10):1942
pubmed: 26242442
Health Qual Life Outcomes. 2017 Jan 24;15(1):20
pubmed: 28118833
Int J Rheum Dis. 2017 Sep;20(9):1105-1119
pubmed: 26990791
Ann Rheum Dis. 2011 Jun;70(6):921-8
pubmed: 21398333
Arthritis Care Res (Hoboken). 2011 Nov;63 Suppl 11:S189-99
pubmed: 22588744
Pharmacoeconomics. 2008;26(5):363-70
pubmed: 18429654
J Hand Surg Am. 2007 Jan;32(1):84-90
pubmed: 17218180
Ann Rheum Dis. 1957 Dec;16(4):494-502
pubmed: 13498604
Arthritis Rheum. 1990 Nov;33(11):1601-10
pubmed: 2242058
Health Qual Life Outcomes. 2006 Oct 11;4:79
pubmed: 17034633
Value Health. 2007 Nov-Dec;10 Suppl 2:S125-37
pubmed: 17995471
Plast Reconstr Surg. 2013 May;131(5):779e-787e
pubmed: 23629117
Osteoarthritis Cartilage. 2016 Apr;24(4):647-54
pubmed: 26620088
J Hand Surg Am. 1998 Jul;23(4):575-87
pubmed: 9708370
Int Orthop. 2008 Aug;32(4):497-504
pubmed: 17370071
Value Health. 2009 Nov-Dec;12(8):1075-83
pubmed: 19804437

Auteurs

Charlotte Panter (C)

Adelphi Values, Patient-Centered Outcomes, Bollington, Cheshire, UK.

Pamela Berry (P)

GSK, Collegeville, PA, USA.
Present Address: Janssen Global Services LLC, Horsham, PA, USA.

Deven Chauhan (D)

Value Evidence and Outcomes, Stockley Park West, 1-3 Ironbridge Road, GSK, Uxbridge, Middlesex, UB11 1BT, UK. deven.k.chauhan@gsk.com.

Sofia Fernandes (S)

GSK, Stevenage, Hertfordshire, UK.

Sally Gatsi (S)

GSK, Collegeville, PA, USA.

Josephine Park (J)

GSK, Collegeville, PA, USA.

Jane R Wells (JR)

Adelphi Values, Patient-Centered Outcomes, Bollington, Cheshire, UK.

Rob Arbuckle (R)

Adelphi Values, Patient-Centered Outcomes, Bollington, Cheshire, UK.

Classifications MeSH